FLUI: Fluicell AB (publ) - Summary | Jitta

Fluicell AB (publ)

SWE:FLUI

Price
kr34.50
Loss Chance
50.8%
3.26JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
17 / 107
154 / 616
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (64)
Recent Business Performance (64)
Financial Strength (40)
Return to Shareholders (0)
Competitive Advantage (50)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2025
New Share IssuedMore than 50% in 5 years
CapExVery High
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
3.26
100.00%
2.89
152.39%
Health Care Equipment
3.60
100.00%
4.20
6.02%
3.04
26.59%
COMPANY DESCRIPTION
Fluicell AB (publ), a life science company, develops and provides clay instruments for 3D bioprinting and cell analysis and flow control on single-cell level in Sweden. The company offers BIOPEN, a powerful tool for high precision cell biology that uses open volume microfluidics; Biozone 6 that generate dose-response curves or study the effects of multiple drug compounds; and Dynaflow Resolve system, an ion channel screening platform, which allows to record various ion channel current in patch clamp recording configuration. It also provides Biopixlar, a 3D single-cell bioprinting platform that produces single cell arrays to organoids and complex tissues; Nexocyte, a platform for universal tissue production; and Biopixlar AER, a single-cell bioprinting platform that fits into a biosafety cabinet. Fluicell AB (publ) was incorporated in 2012 and is based in Mölndal, Sweden.